US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

69.80

+2.834.23%

Post-market: 69.900.0975+0.14%16:10 EDT

Volume:858

Turnover:59.77K

Market Cap:698.09K

PE:- -

High:70.05

Open:69.80

Low:69.34

Close:66.97

52wk High:85.03

52wk Low:55.75

Shares:10.00K

Float Shares:10.00K

Volume Ratio:4.75

T/O Rate:8.58%

Dividend:2.08

Dividend Rate:2.97%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GSK Slides Friday, Underperforms Market

Adlai Nortye's KRAS Opportunity Further Validated by GSK-Hutchmed Deal, Oppenheimer Says

MT Newswires Live

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

GSK Advances Early-Stage Lung Drug With New Formulation Study

GSK Slips Thursday, Underperforms Market

GSK’s Pediatric Asthma Trial Signals Long-Term Upside in Biologic Market

GSK Names Tina Graves President, General Manager for Canada

GlaxoSmithKline (GSK) Gets a Hold from Deutsche Bank

GSK US President Sells Over 44,000 American Depositary Shares

GSK Says Chronic Hepatitis B Treatment Approved in Japan

MT Newswires Live

GSK Says Jemperli Accepted for Priority Review as Potential Treatment for Rectal Cancer

MT Newswires Live

GSK wins first global approval for hepatitis B functional cure in Japan

GSK’s New COPD Bet: Felcorekibart Enters Phase 3 With Long-Term Upside Potential

GSK’s New Phase 3 Asthma Trial Sets the Stage for the Next Wave in Respiratory Growth

BMO starts Exelixis at Market Perform into patent cliff

GSK Executives Add ADS Through Dividend Reinvestment Plans

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires Live

China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks

GSK Executives Acquire Shares Under Company Reward Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/GSKH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":69.8025,"timestamp":1789416000000,"preClose":66.9705,"halted":0,"volume":858,"hourTrading":{"tag":"盘后","latestPrice":69.9,"preClose":69.8025,"latestTime":"16:10 EDT","volume":6,"amount":418.815,"timestamp":1789416603786,"change":0.0975,"changeRate":0.001397,"amplitude":0},"delay":0,"changeRate":0.042287275740811155,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Closed","change":2.832,"latestTime":"09-14 16:00:00 EDT","open":69.8,"high":70.05,"low":69.34,"amount":59772,"amplitude":0.010602,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":66.9705,"nav":66.979706,"aum":669864.039706,"dividendRate":0.029742,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":69.9,"preClose":69.8025,"latestTime":"16:10 EDT","volume":6,"amount":418.815,"timestamp":1789416603786,"change":0.0975,"changeRate":0.001397,"amplitude":0},"volumeRatio":4.745573,"impliedVol":0.1896,"impliedVolPercentile":0.4649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.745573,"shares":10001,"dividePrice":2.0761,"high":70.05,"amplitude":0.010602,"preClose":66.9705,"low":69.34,"week52Low":55.7526,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":69.8025,"eps":0,"divideRate":0.029742,"volume":858,"delay":0,"ttmEps":0,"open":69.8,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":69.5112,"twentyDayClose":68.9018,"sixtyDayClose":73.2027},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665535183","title":"GSK Slides Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665535183","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665535183?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:09","pubTimestamp":1788538140,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares slipped 1.07% to GBP18.47 Friday, on what proved to be an all-around mediocre trading session for the stock market, with the FTSE 100 Index  holding steady at 10,831.09.GSK PLC closed 19.08% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 3.6 million, compared to the 50-day average of 7.5 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","BK4588","LU1829250122.USD","BK4007","GSK.UK","BK4585","BK4532","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664135884","title":"Adlai Nortye's KRAS Opportunity Further Validated by GSK-Hutchmed Deal, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664135884","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664135884?lang=en_us&edition=fundamental","pubTime":"2026-09-04 23:09","pubTimestamp":1788534579,"startTime":"0","endTime":"0","summary":"Adlai Nortye  stands to benefit from the GSK -Hutchmed  deal, which validates growing interest in targeted KRAS therapies, Oppenheimer said in a note emailed Friday.Hutchmed said Thursday its unit licensed rights to GSK to develop and commercialize experimental cancer treatment HMPL-A830 outside Greater China.HMPL-A830 is an EGFR-targeted antibody-drug conjugate carrying a KRAS inhibitor payload. The deal highlights increasing interest in targeted approaches that aim to improve the therapeutic index of RAS-pathway inhibition, Oppenheimer analysts said.Adlai Nortye's approach is differentiated, with AN9025 already in the clinic and data expected in H1 2027. AN4035 uses a pan-RAS inhibitor payload with a CEACAM5-targeting antibody, which could provide advantages in breadth, durability, and target selection, the analysts added.The deal should improve \"investor awareness of comparable RAS-focused platforms and reinforce the strategic value embedded within Adlai Nortye's differentiated RAS ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU2133065610.SGD","LU1854104046.USD","LU0124384867.USD","LU0724618433.USD","IE00BD6J9T35.USD","ONG","GSK","LU0348723411.USD","LU1978683503.SGD","ALN","BK4141","LU1861220033.SGD","GSK.UK","BK4139","LU2298322129.HKD","BK4588","GSKH","IE00BZ199S13.USD","LU1854103824.USD","ON","ANL","LU1548497426.USD","ANL.AU","LU2360107325.USD","LU1861215975.USD","BK4512","LU1720051108.HKD","ONX","BK4007","BK4605","BK7104","IE00BFMHRM44.USD","LU2357305700.SGD","LU1861219969.SGD","LU1983260115.SGD","LU1829250122.USD","LU1720051017.SGD","BK4532","LU1861214812.USD","HCM","BK4531"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664080500","title":"Sector Update: Healthcare Stocks Higher Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664080500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664080500?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:49","pubTimestamp":1788457760,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF  up 0.1%.The iShares Biotechnology ETF  eased 0.3%.In corporate news, Hutchmed  shares jumped 17% after the company said its unit licensed rights to GSK  to develop and commercialize experimental cancer treatment HMPL-A830 outside greater China. GSK shares added 0.8%.AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share. AbbVie shares were down 0.3%.Ultragenyx Pharmaceutical  shares fell 45% after the firm said a phase 3 study of apazunersen in Angelman syndrome did not achieve the primary endpoint nor a key secondary endpoint.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PPH","LU0820561909.HKD","LU1989772923.USD","IE0004445239.USD","MEDX","RARE","LU0708994859.HKD","HCM","ABBV","APGE","BK4137","GLAM","FHLC","LU1496350171.SGD","BK4534","IYH","LU0128525929.USD","LABU","HCSG","LU1718418525.SGD","PJP","GSK.UK","LU1236620750.USD","IXJ","GSK","LU2125909593.SGD","TRUH","VHT","LU0029864427.USD","GSKH","LU0553294199.USD","JDOC","LU0124676726.USD","LU0432979614.USD","RXL","IBB","SBIO","IE00BJJMRZ35.SGD","LU0203345920.USD","LU0114720955.EUR","LU1244550577.SGD","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","XLV","XBI","LU0289961442.SGD","FTXH","AGNG","LU2237443382.USD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648001328.SGD","IE000F7OJYX1.SGD","ELIL","LU0211331839.USD","LU1069344957.HKD","LU2471134952.CNY","LU1267930813.SGD","BMED","LU1093756168.USD","LU2125909247.SGD","SGXZ51526630.SGD","LU2168564222.USD","LU2357305700.SGD","IE0034235303.USD","LU1236620750.USD","NVOC","LU1674673691.USD","LU0820561818.USD","LU1037948541.HKD","IE0000B7K699.USD","LU2089984988.USD","LU0006306889.USD","LU1228905037.USD","LU0210528500.USD","LU2487616109.SGD","LU1814569148.SGD","LU0965509010.AUD","LU1983299246.USD","MEDI","IE00BKVL7J92.USD","LU2461242641.AUD","LU2462157665.USD","LU0289739343.SGD","LU2063271972.USD","GILD","LU0289961442.SGD","LU2168564495.EUR","LU2361044865.SGD","LU0070217475.USD","IE00B3T34201.USD","LU0985481810.HKD","LU2456880835.USD","LU1043141123.HKD","IE00B1BXHZ80.USD","LU0097036916.USD","LU0353189680.USD","LU1069347547.HKD","IE0002270589.USD","LU1116320737.USD","LU1868836591.USD","LU1923622614.USD","LU0912757837.SGD","SG9999002232.USD","LU0128525929.USD","LU0174119429.USD","LU1670711123.USD","IE00BJJMRZ35.SGD","IE000BZT7R73.USD","IE00B7SZLL34.SGD","LU1934455194.USD","IE00BLSP4239.USD","NVOH","SG9999015978.USD","LU2129689431.USD","IE00BJT1NW94.SGD","LU1699723380.USD","LU0094547139.USD","LU1043141396.HKD","LU0640476718.USD","LU1979441026.SGD","LU0198837287.USD","LU1934455863.HKD","LU2087625088.SGD","LU0942090050.USD","IE00B7KXQ091.USD","LU1670628061.USD","BK4583","IE00BJLML261.HKD","LLYX","LU2357627491.SGD","LU0158827781.USD","FHLC","IE00BDGV0183.EUR","PBE","LU0353189763.USD","MEDX","PFE","LU1064131342.USD","LU1868836757.USD","IE00B42XCP33.USD","LU2023250330.USD","SG9999001176.SGD","LU1868836914.USD","LU1323610961.USD","IE0004445015.USD","LU0472753341.HKD","LU2417539215.USD","LU0208291251.USD","LU0114720955.EUR","BK4007","LU0122379950.USD","IE00BFXG1179.USD","BK4533","LU1430594728.SGD","LU2552382132.HKD","LU2168564149.EUR","LU2237438978.USD","LU1670711040.USD","LU2746668461.USD","LU1894683348.USD","LU2750360641.GBP","LU0553294199.USD","IE00B19Z3581.USD","LU1035775433.USD","THNR","ELIS","BK4599","IE000MB6IJN5.SGD","LU1196500208.SGD","LU1244550494.USD","LU0256863902.USD","LU0385154629.USD","LU1941712348.USD","LU0820562030.AUD","LU0345769128.USD","XLV","LU2237443622.USD","LU1035773651.USD","SGXZ99366536.SGD","LU1670710588.SGD","LU1988902786.USD","LU1974910355.USD","BK4578","LU2491049909.HKD","IE00BN8TJ469.HKD","LU2242652126.USD","LU2236285917.USD","LU0109391861.USD","IE00B4JS1V06.HKD","LU0354030438.USD","SG9999014575.USD","IE00B2B36J28.USD","LU2756315664.SGD","LU0069063385.USD","LU1201861249.SGD","LU0787776722.HKD","IE0002141913.USD","LU0395794307.EUR","TMED","CSL.AU","BK4516","IHE","IE0001KFT4U8.USD","LU1778281490.HKD","LU0057025933.USD","IE00BWXC8680.SGD","LU1496350171.SGD","LU1868837136.USD","GB00BDT5M118.USD","HRTS","LU1629891620.HKD","LU1883839398.USD","LU2360032135.SGD","LU0882574139.USD","LU1267930730.SGD","LU2896262040.SGD","NVOX","LU0320765059.SGD","LU0795875169.SGD","LU0267386448.USD","LU1718418525.SGD","LU0354030511.USD","LU2023250843.SGD","TRUH","LU0994945656.USD","SG9999014914.USD","LU2264538146.SGD","LU1914381329.SGD","LU0345770308.USD","LU2361044949.HKD","WDNA","LU0683600562.USD","LU0965509101.SGD","LU0210536198.USD","LU1236620834.HKD","SG9999015358.SGD","LU0203345920.USD","LU0211327993.USD","LU1548497426.USD","LU1989771016.USD","LU2471134523.USD","BK4581","LU1720051108.HKD","MHIP","LU0225771236.USD","LU0203202063.USD","LU2108987350.USD","BK4592","LU0432979614.USD","LU0820561909.HKD","BK4585","LU2028103732.USD","LU0795875086.SGD","AZN","SG9999002224.SGD","LU1093756325.SGD","LU2087621335.USD","LU0109394709.USD","LU0130517989.USD","LU1221951129.SGD","ILDR","LU1670710661.SGD","LU1261432733.SGD","LU0823416689.USD","LU2430703095.HKD","SG9999001440.SGD","LU2462591350.SGD","IE00BK4W5L77.USD","IXJ","LU1023059063.AUD","LU0234570918.USD","LU2237443978.SGD","LU2750360997.AUD","LU1585245621.USD","LU1868837300.USD","LU0170899867.USD","LU0320765992.SGD","LU0672654240.SGD","SG9999014567.USD","LU1267930573.SGD","LU0203347892.USD","PPH","LU2129689605.HKD","IE00B19Z3B42.SGD","LLII","IE00BFTCPJ56.SGD","LU2552382215.SGD","LU0980610538.SGD","GDOC","LU1066051811.HKD","LU0949170772.SGD","LU1366192091.USD","LU2360106947.USD","SG9999014542.SGD","LU0124676726.USD","LU1712237335.SGD","SG9999015986.USD","LU0320765646.SGD","BK4505","LU2023251221.USD","LU2125154778.USD","IE00BKDWB100.SGD","BK4559","LU2491050071.SGD","SG9999014559.SGD","IE00BKPKM429.USD","LU0061475181.USD","LU2491050154.USD","BK4534","LU0471298694.HKD","LU1059921491.USD","LU0310799852.SGD","LU0965508806.USD","LU1057294990.SGD","BBIO","LU0321505868.SGD","LU2089284900.SGD","06160","GSK","IE00BFSS7M15.SGD","LU2237443382.USD","LU2430703178.SGD","IE00BBT3K403.USD","LU0545562505.USD","NVS","ABBV","LU0708995401.HKD","LU2242646821.SGD","LU2471134879.HKD","LU1935042991.SGD","LU0029864427.USD","IE00BVYPNW00.USD","IE00BJJMRX11.SGD","BK7511","IE0004445239.USD","IE00B775H168.HKD","JNJ","LU0158827948.USD","LU0053666078.USD","LU1506573853.SGD","LU2756315318.SGD","LU1267930490.SGD","AGNG","LU0154236417.USD","BK4504","SG9999018857.SGD","LU1032466523.USD","LU1929549753.HKD","LU2125154935.USD","LU0266013472.USD","LU0786609619.USD","SG9999001176.USD","LU1941712264.USD","IE0009355771.USD","LU0985320562.USD","LU0316494557.USD","LU2211815571.USD","LU2433249047.HKD","BK7067","RXL","LU0466842654.USD","LU2430703251.USD","IE00BGHQF631.EUR","LU1989772840.SGD","LU1720051017.SGD","LU2213496289.HKD","SG9999014880.SGD","BK4550","BK4566","IE00B1XK9C88.USD","LU1674673428.USD","LU1232071149.USD","LU1291159041.SGD","04332","SGXZ81514606.USD","BK0239","LU0861579265.USD","LU1221951046.USD","LU2347655156.SGD","LU0306807586.USD","IBBQ","GLAM","LU1934455277.USD","LU1244550221.USD","LU0345769631.USD","BK4568","SG9999015952.SGD","LU2111349929.HKD","LU1061106388.HKD","LU0708994859.HKD","OZEM","LU0162691827.USD","SGXZ57979304.SGD","LU2237443549.SGD","LU0098860793.USD","LU2271345857.HKD","LU2112291526.USD","CANC","LU0689472784.USD","LU0943347566.SGD","SG9999013999.USD","LU2361045086.USD","LU0792757196.USD","GSKH","LU1145028129.USD","LU2347655073.USD","SGXZ31699556.SGD","LU0320765489.SGD","IYH","MRK","LU1066051498.USD","LU0070302665.USD","LU0868494617.USD","SG9999014906.USD","LU2324357040.USD","LU0072461881.USD","LU0889565916.HKD","LU0289739699.SGD","LU1551013425.SGD","IE00BZ1G4Q59.USD","LU1691799644.USD","LU0237698245.USD","LU1829250122.USD","SG9999017495.SGD","LU1670627923.USD","IE00BK4W5M84.HKD","LU0211328371.USD","LU0130102774.USD","LU2505996681.GBP","IE000M9KFDE8.USD","LU2237443465.HKD","IE00BJJMRY28.SGD","LU0964807845.USD","ONC","FTXH","LU2746668974.SGD","LU2471134796.USD","LU1162221912.USD","LU1127390331.HKD","AZNH","BK7501","SG9999015945.SGD","LU0133085943.USD","LU1074936037.SGD","LU1989772923.USD","BMY","LU2592432038.USD","LU0058720904.USD","LU2125909593.SGD","NVO","LU0306806265.USD","LU0345770993.USD","LU1732799900.SGD","LU1839511570.USD","LU0106261372.USD","LU2133065610.SGD","LU0882574055.USD","LU2023250504.SGD","LU2168564065.EUR","LU0477156953.USD","IE00BLSP4452.SGD","LU2106854487.HKD","LU0096364046.USD","LU2265009873.SGD","IE0005OL40V9.USD","LU1917777945.USD","IE00BN29S564.USD","LU0417517546.SGD","IE00BVYPNV92.GBP","LU0689626769.HKD","CURE","JDOC","LU0545039389.USD","LU0079474960.USD","LU1121112475.USD","LU1003077747.HKD","LU2237443895.HKD","SGXZ80539844.SGD","LU1066051225.USD","AMGN","LU0265550946.USD","IBB","BK4588","LU2552382058.USD","LU0310800379.SGD","LU0889566641.SGD","LU0471298777.SGD","IE000WAW04H5.SGD","LLYZ","PAWZ","IE00B4R5TH58.HKD","LU0225284248.USD","LU0965509283.SGD","LU1116320901.HKD","PJP","LU0823434740.USD","IE000SO60NU8.SGD","LU1496350502.SGD","LLY","IE00BSNM7G36.USD","LU0456855351.SGD","LU0203201768.USD","LU1732800096.USD","LU1551013342.USD","LU1032955483.USD","LU1066053197.SGD","LU0323591593.USD","VHT","SG9999015341.SGD","LU0321505439.SGD","LU1244550577.SGD","SG9999018865.SGD","LU0868494708.USD","LU2403377893.USD","BK4532","LU2089283258.USD","REGN","LU1894683264.USD","BK7508","LU0238689110.USD","IE00BFSS8Q28.SGD","LU0426417589.USD","BK4139","LU1623119135.USD","LU2129689514.USD","LU2505996509.AUD","LU0823434583.USD","SG9999003800.SGD","SG9999011175.SGD","688235","LU0859254822.USD","LU2168563687.JPY","LU2468319806.SGD","LU0511384066.AUD","LU1280957306.USD","LU2362541273.HKD","LU2362541513.USD","LU0661504455.SGD","LU0234572021.USD","LU0256863811.USD","IE00B3PB1722.GBP","LU0738911758.USD","GSK.UK","LU1228905540.USD","LU0225283273.USD","LU0726765562.USD","SG9999014898.SGD","LU0265550359.USD","LU1804176565.USD","BBH","BIB","LU0426412945.USD","LU1571399168.USD","LU2362540622.SGD","LU2596442595.SGD","LU2602419157.SGD","TBXU","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662108497","title":"GSK Advances Early-Stage Lung Drug With New Formulation Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2662108497","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662108497?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:30","pubTimestamp":1787848239,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is running a new early stage trial called “A Phas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-early-stage-lung-drug-with-new-formulation-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-early-stage-lung-drug-with-new-formulation-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","GSKH","BK4007","BK4532","BK4585","GSK.UK","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662081745","title":"GSK Slips Thursday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2662081745","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662081745?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:06","pubTimestamp":1787846760,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of GSK PLC  dropped 2.50% to GBP18.52 Thursday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index  falling 0.79% to 10,792.54.GSK PLC closed 18.84% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 3.1 million, compared to the 50-day average of 7.8 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","GSK","BK4532","GSK.UK","LU1829250122.USD","GSKH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745112","title":"GSK’s Pediatric Asthma Trial Signals Long-Term Upside in Biologic Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745112?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:31","pubTimestamp":1787761877,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running a phase 3 study called “A Study of Depemokim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-pediatric-asthma-trial-signals-long-term-upside-in-biologic-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-pediatric-asthma-trial-signals-long-term-upside-in-biologic-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","GSK.UK","BK4532","LU1829250122.USD","GSK","BK4585","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662716056","title":"GSK Names Tina Graves President, General Manager for Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2662716056","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662716056?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:05","pubTimestamp":1787745915,"startTime":"0","endTime":"0","summary":"GSK names Tina Graves president, general manager for CanadaGSK appointed Tina Graves as President and General Manager for its Canada business.She most recently ran GSK Taiwan as vice president and gen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL1D97Sm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4532","BK4007","GSK","LU1829250122.USD","BK4585","GSKH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782777","title":"GlaxoSmithKline (GSK) Gets a Hold from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782777","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662782777?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:36","pubTimestamp":1787646968,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline today and set a price target of £20.00. According to TipRanks,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-deutsche-bank-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-deutsche-bank-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","GSK.UK","BK4532","LU1829250122.USD","GSK","BK4552","DB","BK4585","BK4566","BK4118","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272115","title":"GSK US President Sells Over 44,000 American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272115","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661272115?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:32","pubTimestamp":1787581945,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. GSK disclosed that Maya Martinez-Davis, its US president and a person discharging manager...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-sells-over-44000-american-depositary-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-sells-over-44000-american-depositary-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","GSK.UK","GSKH","BK4007","BK4532","LU1829250122.USD","BK4107","BK4585","BK4117","BK4588","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661229747","title":"GSK Says Chronic Hepatitis B Treatment Approved in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661229747","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661229747?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:06","pubTimestamp":1787558796,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced on Monday that Japan's Ministry of Health, Labor and Welfare has approved the company's drug Hibsago, or bepirovirsen, as a functional cure for  chronic hepatitis B virus infection","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4585","LU1829250122.USD","GSK","BK4532","GSKH","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661522642","title":"GSK Says Jemperli Accepted for Priority Review as Potential Treatment for Rectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661522642","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661522642?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:28","pubTimestamp":1787556522,"startTime":"0","endTime":"0","summary":"GSK's (GSK) Jemperli has been accepted by the US Food and Drug Administration for priority review of its supplemental biologics license application for patients with previously untreated rectal cancer","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSKH","BK4588","LU1829250122.USD","BK4007","GSK.UK","BK4585","BK4532","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661253122","title":"GSK wins first global approval for hepatitis B functional cure in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661253122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661253122?lang=en_us&edition=fundamental","pubTime":"2026-08-24 14:16","pubTimestamp":1787552216,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. Japan’s Ministry of Health, Labour and Welfare has granted the first global approval for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-wins-first-global-approval-for-hepatitis-b-functional-cure-in-japan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-wins-first-global-approval-for-hepatitis-b-functional-cure-in-japan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GSK","GSK.UK","BK4585","LU1829250122.USD","GSKH","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661629484","title":"GSK’s New COPD Bet: Felcorekibart Enters Phase 3 With Long-Term Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2661629484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661629484?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:32","pubTimestamp":1787329951,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The PERSIST COPD-1 trial from GlaxoSmithKline tests GSK5784283, also ca...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-copd-bet-felcorekibart-enters-phase-3-with-long-term-upside-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-copd-bet-felcorekibart-enters-phase-3-with-long-term-upside-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4588","GSKH","BK4532","GSK.UK","BK4007","BK4585","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661874294","title":"GSK’s New Phase 3 Asthma Trial Sets the Stage for the Next Wave in Respiratory Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661874294","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661874294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:32","pubTimestamp":1787329944,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The PERSIST ASTHMA-1 study, officially titled a Phase 3 randomized tria...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-phase-3-asthma-trial-sets-the-stage-for-the-next-wave-in-respiratory-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-phase-3-asthma-trial-sets-the-stage-for-the-next-wave-in-respiratory-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4532","BK4007","BK4585","GSKH","GSK","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492411","title":"BMO starts Exelixis at Market Perform into patent cliff","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492411?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:30","pubTimestamp":1787085023,"startTime":"0","endTime":"0","summary":"BMO Capital initiated coverage of Exelixis (EXEL) with a Market Perform rating and $54 price target Exelixis is anchored by cabozantinib, a “durabl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTH","RSPH","BK4207","AZNH","JDOC","BK4585","RXL","EXEL","CURE","BK4532","FBT","LU2322448791.USD","TMED","BME","BK4588","MEDI","TRUH","FHLC","LU2272731782.SGD","XPH","SYNB","LU2473716301.USD","PPH","IE00B5TLWC47.USD","MEDX","LU2272731600.USD","BMO","PJP","RXD","FTXH","IBB","IHE","LU2322448957.HKD","GSKH","BBH","USRD","LU1992135472.HKD","BK4139","FXH","PBPH","LU1992135399.USD","LU2272731865.HKD","IYH","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660493225","title":"GSK Executives Add ADS Through Dividend Reinvestment Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2660493225","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660493225?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:33","pubTimestamp":1787063592,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. GSK disclosed several routine share transactions by senior executives involving the acqui...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-add-ads-through-dividend-reinvestment-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-add-ads-through-dividend-reinvestment-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","BK4532","BK4007","BK4585","GSKH","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660323436","title":"European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660323436","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660323436?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:12","pubTimestamp":1786979555,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week tracking modestly higher late Monday morning, rising 0.31% to 1,970.56 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies argenx  and DBV Technologies , which climbed 16% and 5.1% respectively. They were followed by telecommunications company Nokia  and biopharmaceutical company Cellectis , which advanced 2.5% and 2% respectively.The decliners from continental Europe were led by medical device maker EDAP TMS  and internet browser company Opera , which dropped 4.6% and 2.7% respectively. They were followed by brewing company Anheuser-Busch InBev  and consumer goods company Unilever , which lost 2.4% and 1.6% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and biopharmaceutical company Akari Therapeutics , which rose 6.3% and 2.8% respectively. They were followed by biopharmaceutical companies GSK  and Bicycle","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","MREO","ULVR.UK","GSKH","IEUR","BUD.AU","BK4592","FOCL","BK4009","IE00BFTCPJ56.SGD","LNOK","TBXU","GSK.UK","AUTL","IBB","AKTX","EPV","UL","BK4169","BK4117","BK4588","BK4107","LU1983260115.SGD","DBVT","LU0889565916.HKD","AFG","DGE.UK","BUD","BK4532","GSK","NOK","WPP","UN","CLLS","DEO","IE0002141913.USD","BCYC","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0823416689.USD","NCNA","LU0006061336.USD","IE00BMPRXN33.USD","LFGY","WPP.AU","BK4505","BK4139","OPRA","FMED","ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108000527","title":"China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks","url":"https://stock-news.laohu8.com/highlight/detail?id=1108000527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108000527?lang=en_us&edition=fundamental","pubTime":"2026-08-14 15:38","pubTimestamp":1786693102,"startTime":"0","endTime":"0","summary":"China Galaxy Securities has released a research report stating that laboratory animals are a fundamental necessity for innovative drug research and development, with deep industry barriers. Two key...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WRND","GDOC","XLVI","BK4585","LFSC","GSKH","06881","BK0276","IBB","BK1564","601881","BK0188","PBE","SBIO","BIOY","BK1147","161027","BK4588","APXH","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659642163","title":"GSK Executives Acquire Shares Under Company Reward Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659642163","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659642163?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:37","pubTimestamp":1786631844,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has disclosed a series of routine share dealings by several senior executives, i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-company-reward-plan-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-company-reward-plan-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","BK4532","BK4007","BK4585","GSKH","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}